Skip to main content

Gynecology-Related Internet Searches Up Following Release of Barbie Movie

Medically reviewed by Carmen Pope, BPharm. Last updated on July 28, 2024.

By Lori Solomon HealthDay Reporter

FRIDAY, July 26, 2024 -- The closing line of the movie Barbie ("I'm here to see my gynecologist") may have spurred public interest in gynecology, according to a research letter published online July 25 in JAMA Network Open.

Eva Senechal, from McGill University in Montreal, and colleagues examined whether public interest in gynecologic care was spurred following the movie Barbie. Analysis included weekly online search volumes in the year preceding and three months following July 21, 2023, for 34 queries related to understanding or seeking gynecologic care, women's health care, or medical care more broadly.

The researchers found that in the week following Barbie's release, there were large increases in the national online search volume for terms referring to gynecologists (51.3 percent) and gynecologist definition (154.1 percent). However, searches were unchanged for gynecologist appointments, suggesting that searches did not translate to new gynecologic care. Searches reflecting broader health interest were also unchanged, supporting the assumption that the observed increase in gynecologist-related searches may have been influenced by the film's release and not other factors.

"Our results suggest that Barbie's closing line may have spurred interest in gynecology, further suggesting the potential influence of popular films on health literacy and awareness," the authors write.

One author disclosed receiving personal fees from the pharmaceutical industry.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

AAO: Corneal Toxicity Reported With Mirvetuximab Soravtansine

TUESDAY, Oct. 22, 2024 -- For patients receiving mirvetuximab soravtansine (MIRV) treatment for primary gynecologic malignancies, corneal toxicity is not uncommon, but usually...

American College of Obstetricians and Gynecologists, May 17-19

The annual meeting of the American College of Obstetricians and Gynecologists was held from May 17 to 19 in San Francisco and was attended by more than 4,000 clinicians...

High Rates of Harassment Behaviors Observed in Obstetrics and Gynecology

THURSDAY, May 9, 2024 -- There are high rates of harassment behaviors within the obstetrics and gynecology (OB-GYN) specialty, according to a review published online May 8 in JAMA...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.